These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25700602)

  • 1. Evidence about inotropes: when is enough, enough?
    Gordon AC
    Intensive Care Med; 2015 Apr; 41(4):695-7. PubMed ID: 25700602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Levosimendan and low cardiac output syndrome. Does mortality really decrease? ].
    Alvarez J
    Rev Esp Cardiol; 2008 May; 61(5):454-7. PubMed ID: 18462647
    [No Abstract]   [Full Text] [Related]  

  • 3. Levosimendan.
    Mason P
    Intensive Crit Care Nurs; 2003 Dec; 19(6):370-1. PubMed ID: 14637297
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levosimendan in acute heart failure: past, present and future].
    Delgado JF
    Rev Esp Cardiol; 2006 Apr; 59(4):309-12. PubMed ID: 16709382
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery].
    García-González MJ; Domínguez-Rodríguez A
    Rev Esp Cardiol; 2006 Aug; 59(8):851-2. PubMed ID: 16938238
    [No Abstract]   [Full Text] [Related]  

  • 6. Testing new drugs for heart failure in children.
    Wessel DL
    Pediatr Crit Care Med; 2006 Sep; 7(5):493-4. PubMed ID: 16960538
    [No Abstract]   [Full Text] [Related]  

  • 7. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
    Elahi MM; Lam J; Asopa S; Matata BM
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
    [No Abstract]   [Full Text] [Related]  

  • 8. Perioperative use of levosimendan: best practice in operative settings.
    Toller W; Algotsson L; Guarracino F; Hörmann C; Knotzer J; Lehmann A; Rajek A; Salmenperä M; Schirmer U; Tritapepe L; Weis F; Landoni G
    J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):361-6. PubMed ID: 22658687
    [No Abstract]   [Full Text] [Related]  

  • 9. [LEVOSIMENDAN--THE FIRST 10 YEARS IN CLINICAL PRACTICE].
    Rybka MM; Lobacheva GV
    Anesteziol Reanimatol; 2015; 60(5):80-4. PubMed ID: 26852586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of levosimendan in acute heart failure patients with symptoms of low cardiac output: case series report].
    Biegus J; Zymliński R; Kulej K; Szachniewicz J; Banasiak W; Jankowska EA; Ponikowski P
    Kardiol Pol; 2013; 71(3):275-8. PubMed ID: 23575784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of levosimendan for low cardiac output syndrome in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
    Koster G; Wetterslev J; Gluud C; Zijlstra JG; Scheeren TW; van der Horst IC; Keus F
    Intensive Care Med; 2015 Feb; 41(2):203-21. PubMed ID: 25518953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium sensitizers--a new group of drugs that increase myocardium contractility].
    Laine M; Lehtonen L; Nieminen MS
    Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of Levosimendan in intensive care treatment of myocardial insufficiency].
    Rehberg S; Ertmer C; Van Aken H; Lange M; Bröking K; Morelli A; Westphal M
    Anaesthesist; 2007 Jan; 56(1):30-43. PubMed ID: 17131137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levosimendan for low cardiac output: a pediatric experience.
    Egan JR; Clarke AJ; Williams S; Cole AD; Ayer J; Jacobe S; Chard RB; Winlaw DS
    J Intensive Care Med; 2006; 21(3):183-7. PubMed ID: 16672640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levosimendan in patients with acute cardiac failure].
    García Graullera Rde J; Sánchez Mécatl MA; Cerda García P; Torreblanca Marín M; Aguirre Sánchez JS; Martínez Sánchez J
    Arch Cardiol Mex; 2005; 75 Suppl 3():S3-55-60. PubMed ID: 16366170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Ferrer-Barba A; Gonzalez-Rivera I; Bautista-Hernandez V
    Curr Vasc Pharmacol; 2016; 14(1):48-57. PubMed ID: 26463985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levosimendan: perpetuum mobile?
    Agewall S; Atar D
    Eur Heart J; 2007 Feb; 28(4):515. PubMed ID: 17283001
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levosimendan and gut mucosal blood flow--not all inotropes are created equal.
    Coopersmith CM
    Crit Care Med; 2005 Jan; 33(1):246-7. PubMed ID: 15644686
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.